April 29th 2025
Jon Giles, MD, speaks to the power of personalized medicine and multidisciplinary care to enhance treatment for patients with rheumatoid arthritis (RA).
Update on Migraine Patient Care Challenges During the Pandemic
October 5th 2021Migraines plague some 35 million Americans, the majority of them women in their 30s and 40s, and disabling pain and symptoms are linked to lost productivity at work, school, and home. On this episode of Managed Care Cast, we bring you an excerpt of an interview with a headache specialist about the extra challenges for patients and providers during the pandemic.
Listen
Study Finds Significant Link Between Obstructive Sleep Apnea, White Matter Hyperintensities
October 5th 2021Patients with obstuctive sleep apnea were found to be significantly more likely to have brain white matter hyperintensities, lesions known to signal brain aging and potential risk of Alzheimer disease.
Read More
Francis Collins, MD, PhD, will step down as director of the National Institutes of Health (NIH) at the end of the year; the Biden administration ends a ban on federal funds for clinics that provide abortion referrals; the Pfizer/BioNTech COVID-19 vaccine is 90% effective in preventing hospitalization and death 6 months after the second dose.
Read More
High Rate of Secukinumab Retention Shown Long Term in Patients With Psoriasis
October 1st 2021Secukinumab was associated with a high rate of short- and long-term drug survival in the treatment of patients with psoriasis, with factors such as obesity and prior biologic use linked to discontinuation of use.
Read More
Patient Characteristics Impact Effectiveness of TKIs in CML and AEs Experienced
October 1st 2021Dosing from pivotal phase 3 trials of tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML) is not optimal for real-world patients who experience different efficacy and adverse events (AEs).
Read More
Contributor: Institutional Engagement With Physicians Is Key to Managing Cost and Quality
September 30th 2021Although physicians’ clinical decisions serve as the biggest drivers behind the cost of care, hospitals have long been reluctant to take financial accountability. If such accountability is to be transformed from a diffuse fear to a manageable managerial task, institutional engagement with physicians will be a critical next step.
Read More
Insulin Pump Use Linked With Decreased Risk of Diabetic Retinopathy in Young Patients With T1D
September 28th 2021Risk of diabetic retinopathy (DR) was found to be decreased in young patients with type 1 diabetes (T1D) who were treated with insulin pumps, with findings also indicating a 2.1-fold greater risk of DR in Black participants compared with White individuals.
Read More
The Drug Enforcement Administration (DEA) issues a warning on fentanyl-laced counterfeit prescription drugs; a new FBI report shows a year-to-year increase in murders nationwide from 2019 to 2020; Pfizer will soon begin testing a novel combination therapy as a preventive measure against COVID-19 infection.
Read More
What's Next After OCM? Possibly a Gap and Something Mandatory, Experts Predict
September 25th 2021With the Oncology Care Model (OCM) slated to end in 2022, the successor model is still not in place. According to panelists, there is likely going to be a gap after OCM ends and the new model begins, but more importantly, practices should prepare for the new model to be mandatory.
Read More
Dr Debra Patt Discusses the Increased Use of Telemedicine and Digital Health During the Pandemic
September 24th 2021The pandemic has acted as a catalyst to increase the use of digital health and telemedicine, allowing providers to continue to deliver great care and even reach their rural patients, said Debra Patt, MD, PhD, MBA, executive vice president of Texas Oncology.
Watch
Addressing Disparities Starts With Engaging the Community
September 24th 2021In the opening sessions at the Patient-Centered Oncology Care® conference, held September 23-24 both virtually and in Nashville, Tennessee, speakers focused on addressing disparities by getting involved and engaged with the community.
Read More
Dr Rajesh Rajpal on the Future of Eye Lens Technology, Cataract Surgery
September 24th 2021Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision, addresses ongoing and future innovations in eye lens technology and instruments for cataract surgery.
Watch
Dr Jeff Patton Outlines How Community Oncology Is a Low-Cost, High-Quality Provider
September 24th 2021Having the option of receiving care in their community instead of a large hospital located hours away is not only a benefit for many patients, but research is showing community oncology practices are a low-cost, high-quality provider of care, explained Jeff Patton, MD, executive chairman of Tennessee Oncology and CEO of OneOncology.
Watch
Dr Elizabeth Kwo on the Expanding Use of Remote Patient Monitoring
September 23rd 2021Remote patient monitoring includes urgent care uses, long-term monitoring to help keep patients with cancer out of the hospital by monitoring the effects of oncology treatment at home, and even voice monitoring to check for altered mental status, said Elizabeth Kwo, MD, MBA, MPH, the deputy chief clinical officer at Anthem BCBS, and a speaker at the 10th anniversary of Patient-Centered Oncology Care® conference.
Watch
Body Surface Area May Predict Risk of Psoriatic Arthritis in Patients With Psoriasis
September 22nd 2021Greater body surface area was shown to correlate with an increased risk of psoriatic arthritis development in patients with psoriasis, with obesity and depression also identified as risk factors.
Read More
Spotlighting Pandemic-Related Challenges, Data-Driven Solutions for Payers
September 21st 2021On this episode of Managed Care Cast, we address how delays in routine care and other aspects of the pandemic are affecting payer organizations today, and how technology innovations like natural language processing can work to empower key initiatives in population health and beyond.
Listen
PCOS Estimated to Cost $8 Billion in Immediate, Long-term Health Issues
September 21st 2021An updated report shows that the long-term cost of treating the health effects of polycystic ovary syndrome (PCOS)—$4.3 billion—is even higher than $3.7 billion it takes to diagnose and treat immediate issues that present for women who are of reproductive age.
Read More
Dr Colleen R. Kelly on the Lack of Evidence to Support Probiotics for C difficile
September 18th 2021Clinicians are finding that there really is no basis to recommend probiotics for patients with Clostridioides difficile infection, that instead they may cause harm, said Colleen R. Kelly, MD, FACG, gastroenterologist and associate professor of medicine at The Warren Alpert Medical School of Brown University.
Watch
States Late to Adopt PrEP Risk Falling Further Behind
September 18th 2021A new analysis of 2014-2018 data among all states plus Washington, DC, for those who have either indications for preexposure prophylaxis (PrEP) or current prescriptions for the preventive treatment, shows a widening gap in PrEP uptake, with states considered early adopters pulling ahead of those considered late adopters.
Read More